Articles Archives - Page 430 of 715

MondayMar 08, 2021 12:05 pm

Relax, Robots Have it Handled

Massive opportunity ahead says CEO of Autonomous Security Robot maker Knightscope Wide ranging interview discloses vast potential in federal applications Knightscope’s state of the art ASRs provide cost effective 24/7/365 security The rise of machines has arrived. Relax, it isn’t the rise of Skynet, the malevolent neural network superintelligence system from the movie Terminator. This rise of machines has no malice. In fact, these machines benefit society by uniquely combining robotics, self-driving technology, and artificial intelligence to reduce crime as well as provide safety, security, and real-time data in a multitude of settings. With the rise of its Autonomous Security…

MondayMar 08, 2021 11:55 am

Ideanomics Inc. (NASDAQ: IDEX) Acquires 20% Stake in Italian Listed Electric Motorcycle Maker Energica

Ideanomics, Inc. (NASDAQ: IDEX) recently entered into an investment agreement promising to purchase over 6 million Energica ordinary shares using a subscribed-shares arrangement that priced each subscribed share at Euro 1.78 In total, IDEX would invest approximately 13 million dollars in the Italy-based manufacturer of all-electric high-performance motorcycles According to IDEX CEO Alf Poor, the investment was driven by Energica’s manufacture of high-performance products that produce zero emissions In 2020, Energica experienced a 187% increase in revenue compared to 2019, and there is high demand for Energica’s motorcycles in the U.S. Ideanomics (NASDAQ: IDEX), a global company focused on investing…

MondayMar 08, 2021 11:07 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) and Canada House Wellness Group (CSE: CHV) Partner, Bringing New Cannabis 2.0 to More Canadians

Canada House subsidiary Abba Medix to distribute Pure Extract line of full spectrum oil vape and edible products throughout its nationwide network Partnership widens Pure Extracts’ footprint in Canada’s growing Cannabis 2.0 market Global extraction product market expected to reach $28.5 billion in next six years New agreement strengthens Pure Extracts’ sales channels as it looks towards international expansion There’s plenty of media coverage about increasing legalization of cannabis for medical and adult recreational use driving a broad market expected to reach $73.6 billion by 2027 (https://ibn.fm/ICOlM), but not as much about the cannabis extraction market that is growing at nearly…

FridayMar 05, 2021 12:35 pm

Brain Scientific Inc. (BRSF) Making EEGs Accessible in Emergency Departments

Head CTs, MRIs are most-used but not most-effective tool for head trauma or neurological issues in triage EEG changed clinical management of 76.2% of patients, even when CT or MRI was available Brain Scientific has overcome key barriers causing EEG underuse in emergency medicine Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is making EEGs accessible in emergency departments (“ED”) with cutting-edge tech that bridges the widening gap in access to quality care. As the public becomes more aware of head trauma's long-term effects, triages fill up with potential TBIs and acute neurological conditions. Facilities are scrambling to adapt to…

FridayMar 05, 2021 12:20 pm

Predictive Oncology Inc. (NASDAQ: POAI) Announces Fundraising Agreements to Raise Estimated $25M

POAI completes two separate fundraising initiatives: private placement, direct offering. Two fundraising campaigns expected to result in $17.6 million, $7.4 million respectively. Predictive Oncology plans to use funds to pay off debt as well as for working capital, general corporate purposes. Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced two funding initiatives that together total an estimated $25 million. The company has entered into securities purchase agreements with institutional and accredited investors (https://ibn.fm/WH4nw) to raise approximately $17.6 million and is involved in a direct offering that is expected…

FridayMar 05, 2021 12:04 pm

Uranium Energy Corp. (NYSE American: UEC) Positioned Favorably to Capitalize on Rising Uranium Demand

Increased nuclear power projects fueling rising demand for uranium UEC controls one of the largest historical uranium exploration and development databases in United States UEC property portfolio includes properties previously explored and developed by senior energy firms UEC has fully licensed, low cost, ISR projects positioned to supply the U.S. Uranium Reserve Nuclear energy included in Democratic Party’s energy platform for first time in 48 years After spending a solid ten years in a downward trend, uranium stocks are now making fresh 52-week highs amid increased demand for energy (https://ibn.fm/GXF7e). Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and…

FridayMar 05, 2021 11:11 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) and WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) Get the Green Light for Clinical Trials’ Protocols from Ethics Panels

CNS Pharmaceuticals holds the exclusive worldwide license to the Berubicin chemical compound Berubicin is CNSP’s lead, novel anthracycline candidate for the treatment of glioblastoma multiforme (“GBM”) that was the subject of a previously conducted Phase 1 clinical trial, which had a clinical benefit response rate of 44% CNSP has sublicensed Berubicin to WPD Pharmaceuticals in 31 countries primarily in eastern Europe and western Asia WPD plans to conduct a Phase 2 trial in adults with GBM and a Phase 1 trial for pediatric patients with malignant gliomas CNSP intends to conduct its own Phase 2, potentially pivotal, trial in s…

ThursdayMar 04, 2021 1:28 pm

RYAH Group Committed to Advancing Telehealth in HIPAA-Compliant Environment

Telehealth sector going through explosive growth; patients' data protection remains key challenge Although relaxed due to COVID-19 outbreak, HIPAA guidelines protecting patients' data security, privacy likely to tighten as pandemic abates RYAH appears ready to respond to strict data security requirements, uses medical data in a HIPAA-compliant setting Telehealth is becoming increasingly popular with patients and doctors alike, but securing the integrity of patient information remains critical. As a company developing proprietary technology supporting a data-driven healthcare approach, RYAH Group appears ready to respond to the strict data security requirements. With patients needing more access to health care, and providers…

ThursdayMar 04, 2021 12:44 pm

SRAX Inc.’s (NASDAQ: SRAX) Sequire Investor Analytics Platform Helps Public Companies Monitor Investors Amid Record-Breaking Microcap Trading Activity

Microcap stocks outperforming 2020 record highs, currently trading at 40% above 200-day moving average SRAX’s Sequire SaaS platform provides public companies with tools to monitor trading activity, provides actionable insights for use in marketing campaigns Sequire subscriber base surged to 3 million active traders across 90 public companies since its 2019 inception Investor interest sent microcap stocks sky-high in 2020, a trend that is continuing well into 2021 with returns on some microcap ETFs surging at several times the rate of comparable large-cap ETFs (https://ibn.fm/Bu86D). As the tide of investor interest continues to flow into microcaps, public companies are leveraging…

ThursdayMar 04, 2021 12:11 pm

Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Newly Acquired Subsidiary Achieves Earn-Out Milestone —Successful Synthesis of Multiple Tryptamine Derivatives

Adelia Therapeutics has achieved earn-out milestones outlined in contribution agreement with Cybin Adelia ideal acquisition for Cybin, as it leads innovation in researching psychedelic treatment options in the mental health space Acquisition results in Cybin obtaining extensive intellectual property portfolio and product pipeline Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, has announced that its recently acquired subsidiary, Adelia Therapeutics Inc., has achieved the earn-out milestones outlined for the time period in the contribution agreement between the two companies (https://ibn.fm/c6o2E). That milestone includes the successful synthesis of multiple tryptamine derivatives.…

Site Search

Company Search

Category: Articles